Skip to main content

What our clients say

“accelopment is simply the best! I have greatly appreciated their expertise, professionalism, and strategic guidance throughout the preparation of the project. Their support was instrumental in helping us secure the project, and I am very pleased that they will remain a key partner, supporting us throughout its implementation and management.“

Prof. Frédéric Affouard

IDEAS Project Coordinator
University of Lille, France

Improving Drug Efficacy with next-generation AmorphouS materials and trained experts

Approximately 70–90% of all new chemical entities and drug molecules under development are reported to have poor aqueous solubility. Since 2000 amorphous forms emerged as one of the most popular strategies in the pharmaceutical industry to enhance the solubility and bioavailability of challenging drugs. However, due to the intrinsic instability of amorphous materials, only a limited number of commercially available products have been developed so far by Europe’s biotech and pharmaceutical industries.

Building on recent technological advances and scientific discoveries by the IDEAS partners, we are convinced that overcoming this major bottleneck requires a more rational approach to the elusive amorphous physical state, transcending the current empirical methods that hinder innovation. This effort demands a unified project bringing together the cross-disciplinary expertise of academic research groups in materials science, physics, chemistry, and pharmacy, alongside industry partners. The network comprises a consortium of 10 beneficiaries (7 universities, 2 large companies, and 1 SME) and 6 associated partners (1 academic and 5 industrial) from 10 EU countries. The IDEAS Doctoral Network is designed to empower a new generation of young scientists in the field of amorphous pharmaceutical systems, strengthening Europe’s biotech/pharma industry and academic innovation capacity. Through this programme, we will train 15 doctoral candidates (DCs) to address key challenges associated with amorphous materials. The fellows will collaborate to develop eco-friendly manufacturing technologies for amorphous materials, establish science-based control over material properties, and explore a wide range of materials to achieve efficient production of high-quality amorphous formulations. This advanced research-driven training will be further enriched with opportunities to develop a broad spectrum of personal, organisational, and impactful skills. This project is currently in grant preparation with the European Commission and set to start on dd month yyyy.

This project is currently in grant preparation with the European Commission.

This project contributes to the UN Sustainable Development Goals (SDGs) 3, 4, 6, 9, 12 and 17.

Facts

Programme:

HORIZON-MSCA-DN

Duration:

01.11.2026 – 31.10.2030

Budget:

4.31 million euro

Area:

Health, biomedical

Our Services:

Proposal Writing
Grant Preparation
Management
Dissemination
Training

Coordinator

Université de Lille, FR

Partners

Università di Pisa, IT
Uniwersytet Sląski w Katowicach, PL
Universitat Politècnica de Catalunya, ES
Janssen Pharmaceutica NV, BE
Université Catholique de Louvain, BE
Trinity College Dublin, IE
MyBiotech GmbH, DE
Zentiva, CZ
Universidade Nova de Lisboa, PT
Instituto Superior Técnico, Universidade de Lisboa, PT
Physiolution GmbH, DE
Linari Engineering, IT
F1 Pharma S.A., PL
UCB Pharma®, BE
accelopment Schweiz AG, CH

Our team

My main goal is to relieve the scientists of their workload so that they can fully concentrate on their projects, and with our support, tackle the challenges of the future.

Jacqueline Strehler

Research & Innovation Project Manager
Marie Skłodowska-Curie ActionsGreen DealHealth
©accelopment Schweiz AG
+41 44 455 66 00 
info@accelopment.com  
ISO 9001 certified
© 2026 accelopment. All rights reserved.